Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning.
Papp L, Pötsch N, Grahovac M, Schmidbauer V, Woehrer A, Preusser M, Mitterhauser M, Kiesel B, Wadsak W, Beyer T, Hacker M, Traub-Weidinger T. Papp L, et al. Among authors: grahovac m. J Nucl Med. 2018 Jun;59(6):892-899. doi: 10.2967/jnumed.117.202267. Epub 2017 Nov 24. J Nucl Med. 2018. PMID: 29175980 Free article.
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact.
Grubmüller B, Baltzer P, Hartenbach S, D'Andrea D, Helbich TH, Haug AR, Goldner GM, Wadsak W, Pfaff S, Mitterhauser M, Balber T, Berroteran-Infante N, Grahovac M, Babich J, Seitz C, Kramer G, Susani M, Mazal P, Kenner L, Shariat SF, Hacker M, Hartenbach M. Grubmüller B, et al. Among authors: grahovac m. Clin Cancer Res. 2018 Dec 15;24(24):6300-6307. doi: 10.1158/1078-0432.CCR-18-0768. Epub 2018 Aug 23. Clin Cancer Res. 2018. PMID: 30139879
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI.
Papp L, Spielvogel CP, Grubmüller B, Grahovac M, Krajnc D, Ecsedi B, Sareshgi RAM, Mohamad D, Hamboeck M, Rausch I, Mitterhauser M, Wadsak W, Haug AR, Kenner L, Mazal P, Susani M, Hartenbach S, Baltzer P, Helbich TH, Kramer G, Shariat SF, Beyer T, Hartenbach M, Hacker M. Papp L, et al. Among authors: grahovac m. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1795-1805. doi: 10.1007/s00259-020-05140-y. Epub 2020 Dec 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33341915 Free PMC article. Clinical Trial.
A Sneak-Peek into the Physician's Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic Stenosis.
Hasimbegovic E, Papp L, Grahovac M, Krajnc D, Poschner T, Hasan W, Andreas M, Gross C, Strouhal A, Delle-Karth G, Grabenwöger M, Adlbrecht C, Mach M. Hasimbegovic E, et al. Among authors: grahovac m. J Pers Med. 2021 Oct 22;11(11):1062. doi: 10.3390/jpm11111062. J Pers Med. 2021. PMID: 34834414 Free PMC article.
Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Spielvogel CP, Stoiber S, Papp L, Krajnc D, Grahovac M, Gurnhofer E, Trachtova K, Bystry V, Leisser A, Jank B, Schnoell J, Kadletz L, Heiduschka G, Beyer T, Hacker M, Kenner L, Haug AR. Spielvogel CP, et al. Among authors: grahovac m. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):546-558. doi: 10.1007/s00259-022-05973-9. Epub 2022 Sep 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 36161512 Free PMC article.
Automated data preparation for in vivo tumor characterization with machine learning.
Krajnc D, Spielvogel CP, Grahovac M, Ecsedi B, Rasul S, Poetsch N, Traub-Weidinger T, Haug AR, Ritter Z, Alizadeh H, Hacker M, Beyer T, Papp L. Krajnc D, et al. Among authors: grahovac m. Front Oncol. 2022 Oct 11;12:1017911. doi: 10.3389/fonc.2022.1017911. eCollection 2022. Front Oncol. 2022. PMID: 36303841 Free PMC article.
57 results